The transcriptional regulator CprK controls the expression of the reductive dehalogenase CprA in organohalide-respiring bacteria.
Desulfitobacterium hafniense
CprA catalyses the reductive dechlorination of the terminal electron acceptor
o
-chlorophenol acetic acid, generating the phenol acetic acid product. It has been shown that CprK has ability to distinguish between the chlorinated CprA substrate and the de-halogenated end product, with an estimated an estimated 10
4
-fold difference in affinity. Using a green fluorescent protein GFP
UV
-based transcriptional reporter system, we establish that CprK can sense
o
-chlorophenol acetic acid at the nanomolar level, whereas phenol acetic acid leads to transcriptional activation only when approaching micromolar levels. A structure–activity relationship study, using a range of
o
-chlorophenol acetic-acid-related compounds and key CprK mutants, combined with p
K
a
calculations on the effector binding site, suggests that the sensitive detection of chlorination is achieved through a combination of direct and indirect readout mechanisms. Both the physical presence of the bulky chloride substituent as well as the accompanying electronic effects lowering the inherent phenol p
K
a
are required for high affinity. Indeed, transcriptional activation by CprK appears strictly dependent on establishing a phenolate–K133 salt bridge interaction, rather than on the presence of a halogen atom
per se
. As K133 is strictly conserved within the CprK family, our data suggest that physiological function and future applications in biosensing are probably restricted to phenolic compounds.